ArticleClinical and experimental gastroenterology2026
Predictors of In-Hospital Mortality in
Article in Clinical and experimental gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: With the global decline in Patients and Methods: We conducted a retrospective cohort study at a quaternary hospital in Barranquilla, Colombia, including all adults (≥18 years) hospitalized with endoscopically confirmed non-variceal UGIB and negative Results: Of 285 patients, the median age was 60 years (IQR: 39-73), and 54% were male. NSAID use was rare (2.8%), whereas antithrombotic exposure was prevalent (28.8%), including low-dose aspirin (18.2%) and dual antiplatelet therapy (4.9%). The most common endoscopic findings were erosive gastropathy (45%) and ulcers (12%). Overall in-hospital mortality was 5% (n=13). In multivariable analysis, age >60 years (aOR: 2.9; 95% CI: 1.7-10.2; p = 0.05), cardiovascular complications (aOR: 7.8; 95% CI: 1.9-32.0; p = 0.004), encephalopathy (aOR: 8.5; 95% CI: 2.2-33.0; p = 0.009), and antiplatelet plus anticoagulant therapy (aOR: 5.3; 95% CI: 1.6-17.5; p = 0.006) were independently associated with in-hospital mortality. Conclusion: In this cohort, in-hospital mortality in non-variceal UGIB patients without
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.